With cardiovascular diseases remaining the leading cause of death worldwide, the urgent need for new treatments has led researchers to nucleic acids. Discover how Professor Stefanie Dimmeler combines basic and clinical research to exploit the fine-tuning capabilities of microRNAs, opening up entirely new possibilities to stabilize blood vessels and protect against heart failure.
Read the arcticle HERE.